These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
36. Intravitreal Sustained-Release Steroid Implants for the Treatment of Macular Edema following Surgical Removal of Epiretinal Membranes. Hattenbach LO; Springer-Wanner C; Hoerauf H; Callizo J; Jungmann S; Brauns T; Fulle G; Eichel S; Koss MJ; Kuhli-Hattenbach C Ophthalmologica; 2017; 237(4):232-237. PubMed ID: 28463851 [TBL] [Abstract][Full Text] [Related]
37. Effectiveness and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema: A Real-World Experience. Mello Filho P; Andrade G; Maia A; Maia M; Biccas Neto L; Muralha Neto A; Moura Brasil O; Minelli E; Dalloul C; Iglicki M Ophthalmologica; 2019; 241(1):9-16. PubMed ID: 30408801 [TBL] [Abstract][Full Text] [Related]
38. Efficacy of vitrectomy combined with an intraoperative dexamethasone implant in refractory diabetic macular edema. Jung YH; Lee Y Acta Diabetol; 2019 Jun; 56(6):691-696. PubMed ID: 30824977 [TBL] [Abstract][Full Text] [Related]
39. Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab for the Treatment of Macular Edema Secondary to Retinal Vein Occlusion in a Chinese Population. Gu X; Yu X; Song S; Dai H Ophthalmic Res; 2017; 58(1):8-14. PubMed ID: 28334720 [TBL] [Abstract][Full Text] [Related]